8-K: Know Labs Holds 2024 Annual Meeting, Elects Directors and Approves Key Proposals

Know Labs held its 2024 Annual Meeting of Stockholders on September 26, 2024, where shareholders elected directors, ratified the accounting firm, and approved the issuance of shares related to convertible notes and warrants.

Summary

• Know Labs held its 2024 Annual Meeting of Stockholders on September 26, 2024.
• A total of 86,777,171 shares were eligible to vote, with 56,964,556 shares represented by proxies, constituting 65.6% of the total shareholders.
• Shareholders elected seven nominees to the Board of Directors to serve until the 2025 Annual Meeting.
• BPM, LLP was ratified as the company's independent registered public accounting firm for the fiscal year ending September 30, 2024.
• The issuance of common stock underlying convertible notes and warrants issued to Lind Global Fund II LP was authorized, in compliance with NYSE American Rule 713.
• A non-binding advisory vote approved the compensation of the company's named executive officers.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures and shareholder engagement, with no significant positive or negative surprises. The authorization of shares for convertible notes is a common practice for raising capital.

Positives

• The company successfully held its annual meeting with a strong shareholder turnout of 65.6%.
• All proposed directors were elected, ensuring continuity in leadership.
• The ratification of BPM, LLP as the independent auditor provides assurance of financial oversight.
• The authorization of shares for convertible notes and warrants with Lind Global Fund II LP allows the company to access capital.

Negatives

• A significant number of broker non-votes were recorded for the director election and share authorization proposals, indicating some shareholders did not provide specific voting instructions.
• The advisory vote on executive compensation was non-binding, meaning the board is not obligated to act on the results.

Risks

• The company's reliance on convertible notes and warrants for financing could potentially dilute existing shareholders.
• The high number of broker non-votes could indicate a lack of engagement from some shareholders.

Future Outlook

The company will hold its next annual meeting in 2025, where the newly elected directors will serve until.

Management Comments

• The company held its 2024 Annual Meeting of Stockholders on September 26, 2024.
• The results of the Annual Meeting are set forth below.

Industry Context

This announcement is a routine corporate governance event for a publicly traded company, ensuring compliance with regulatory requirements and shareholder engagement.

Comparison to Industry Standards

• The shareholder turnout of 65.6% is within the typical range for annual meetings of publicly traded companies, although higher engagement is generally preferred.
• The ratification of an independent accounting firm is a standard practice for public companies to ensure financial transparency and compliance.
• The authorization of shares for convertible notes and warrants is a common method for raising capital, particularly for emerging growth companies.

Stakeholder Impact

• Shareholders have voted on key matters, including the election of directors and the ratification of the accounting firm.
• The authorization of shares for convertible notes and warrants may impact shareholder equity.
• The non-binding advisory vote on executive compensation provides shareholders with a voice on executive pay.

Next Steps

• The newly elected directors will serve on the board until the 2025 Annual Meeting of Stockholders.
• The company will continue to operate with BPM, LLP as its independent registered public accounting firm for the fiscal year ending September 30, 2024.

Key Dates

Keywords

Annual Meeting, Board of Directors, Shareholders, BPM LLP, Convertible Notes, Warrants, NYSE American, Executive Compensation, Lind Global Fund II LP, Proxy Statement